1 11. 2 Abe C, Hirano K, Wada M, et al. Resistance to Mycobacterium tuberculosis to four first line antituberculosis drugs in Japan, 1997. Int J Tubercle Lung Dis 2001;5:46-52. 3 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, Supplement 2: Diagnosis and Treatment of Latent TB Infection and Active TB, 1994. 4 ATS, CDC:Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47. 5 :2. 2000. 2000p13-18. 6 Metchock BG, Nolte FS, Wallace RJ,Jr:Mycobacterium. In:Manual of Clinical Microbiology (Lennete EH, et al. ed, 7 th ed). ASM, NY (1999) P399-437. 7 :3. 2000. 2000p19-26. 8 :4. 2000. 2000p27-42. 9 :6. 2000. 2000p78-95. 10 Iinuma Y, Ichiyama S, Yamori S, et al. Diagnostic value of the Amplicor PCR assay for initial diagnosis and assessment of treatment response for pulmonary tuberculosis. Microbiol Immunol 1998;42:281-287. 11 ASM: Clinical Microbiology Procedures Handbook, vol. 2, Section 14. Biohazards and Safety. ASM, Washington, DC. 1995. 12 CDC and NIH:Biosafety in Microbiological and Biomedical Laboratories 4 th ed, 1999. 13 CDC:Goals for working safety with Mycobacterium tuberculosis in clinical, public health, and research laboratories, 1997. 14 Garner JS, the Hospital Infection Control Practices Advisory Committee. Guidelines for Isolation Precautions in Hospitals. Am J Infect Control 1996;24:24-31. 15 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, Supplement 1 : Determining of the Infectiousness of a TB Patient, 1994. 16 Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet1999;353(9151):444-9. 17 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, II Recommendations : E. Management of Hospitalized Patients Who Have Confirmed or Suspected TB, 1994. 18 Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-1144. 19 van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;341:1174-1179. 20 Caminero JA, Pena MJ, Campos-Herrero MI, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med 2001;163:717-20. 21 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, II Recommendations : F. Engineering Control Recommendations, 1994. 22 Riley RL. Airborne infection. Am J Med 1974;57:466-75. 23 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, II Recommendations : G. Respiratory Protection, 1994. 24 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, Supplement 5: Decontamination-Cleaning, Disinfecting, and Sterilizing of Patient-Care Equipment, 1994. 25 CDC : Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations, 1995. 26 Bolyard EA, Tablan OC, Williams WW, et al. Guideline for infection control in healthcare personnel, I E. 19 and II G. 19 Tuberculosis. Infect Control Hosp Epidemiol 1998;19:407-63. 27. 7 1989 28 CDC:The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States, 1996. 29 Rodrigues L, Diwan D, Wheeler J. Protective effect of BCG against tuberculosis meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8.
30 Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702. 31 Comstock GW : How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-850. 32 Chaisson RE. New developments in the treatment of latent tuberculosis. Int J Tuberc Lung Dis. 2000;4:S176-81. 33. 2 3. 2000. 34 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, II Recommendations : D. Management of Patients Who May Have Active TB in Ambulatory-Care Setting and Emergency Departments, 1994. 35 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, II Recommendations : H. Cogh-Inducing and Aerosol-Generating Procedures, 1994. 36 CDC : Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, II Recommendations : M. Additional considerations for selected areas in health-care facilities and other health-care settings, 1994. 37. 3 3. 2000. 38 Driver CR, Valway SE, Morgan WM, et al., Transmission of Mycobacterium tuberculosis associated with air travel. JAMA 1994;272:1031-5. 39 Yusuf HR, Braden CR, Greenberg AJ, et al., Tuberculosis transmission among five school bus drivers and students in two New York counties. Pediatrics 1997;100:E9.